Delcath Systems price to book ratio DCTH
Market value divided by the book value of the company's net assets, since 2018.
- Today, Oct 23, 2026
- 4.1×
- 8-year median
- 4.8×
- Against its 8-year history
- 38th
- percentile: 0 is its lowest day, 100 its highest
- 8-year range
- 0.1× to 75.3×
- Peer median
- 3.1×
Delcath Systems' price to book ratio is 4.1× as of Oct 23, 2026.
That is below its 8-year median of 4.8×, close to the middle of its last 8 years.
Over that time it ranged from 0.1× in May 2018 to 75.3× in Oct 2024.
The median for 10 medical instruments and supplies stocks of a similar size is 3.1×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 4.1× | 2.8× | 4.9× |
| 2025 | 3.2× | 2.7× | 60.7× |
| 2024 | 44.6× | 3.5× | 75.3× |
| 2023 | 3.7× | 2.2× | 3.7× |
| 2022 | 6.6× | 3.8× | 7.3× |
| 2021 | 4.9× | 3.1× | 27.2× |
| 2020 | 22.5× | 5.0× | 22.5× |
| 2019 | n/m a value too high to mean anything | ||
| 2018 | 0.1× | 0.1× | 0.1× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Delcath Systems' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| DCTHDelcath Systems | 4.1× |
| TCMDTactile Systems Technology | 2.4× |
| MDXGMimedx | 2.6× |
| EMBCEmbecta | n/m |
| MOVMovado | 1.4× |
| INFUInfuSystem | 4.7× |
| UTMDUtah Medical Products | 1.9× |
| IRMDIradimed | 10.8× |
| STAAStaar Surgical | 3.1× |
| PDEXPro DEX | 4.2× |
| BVSBioventus | 5.5× |
| Peer median | 3.1× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Delcath Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.